What is LL-37 researched for?

Research applications for LL-37

LL-37 has been studied in the context of restoration research. A human cathelicidin antimicrobial peptide researched for broad-spectrum antimicrobial, immunomodulatory, and wound-healing properties.

Research programmes involving LL-37 generally fall into three broad categories: mechanism-of-action studies (how the peptide interacts with targets), comparative studies (how it differs from related compounds), and quality/analytical studies (how to verify purity and identity in the lab).

Commonly asked research questions

What is LL-37?
LL-37 is the only cathelicidin-derived antimicrobial peptide found in humans. It is studied in the antimicrobial, immune-modulation, and epithelial-barrier research literature.

What is LL-37 researched for?
Published preclinical research has examined LL-37 in antimicrobial-pathway, immune-signalling, and epithelial-barrier studies. It is one of the most-studied endogenous host-defence peptides in the in-vitro literature.

What purity does Peptify LL-37 meet?
Peptify LL-37 is 99%+ HPLC-verified with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.

Research-use framing

All content here is provided as a reference for qualified researchers. Peptify does not make therapeutic claims and does not sell products for human or animal consumption.

Buy LL-37 for research

99%+ HPLC-verified LL-37 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.

• LL 37 5MG

Frequently asked questions